MMR testing was performed in 71·8% ( N = 34,664) of newly diagnosed colorectal cancers with an increasing trend to 88·8% coverage in the study's final year.
← all excerpts
A registry-based study on universal screening for defective mismatch repair in colorectal cancer in Denmark highlights disparities in screening uptake and counselling referrals.
1
—
—